Research & Economic Development

Office of the Vice Chancellor

Coronavirus Disease 2019 (COVID-19) Agency Updates

Truman Medical Centers (TMC) Information specific to COVID-19 and actions being taken at TMC.
University Libraries Researcher and Clinical Resources
CITI Program COVID-19 Resources CITI Program has compiled these resources to help the research community prepare for and manage the challenges presented by the outbreak of COVID-19. Visit this page often as we will update this list with new resources as they become available along with important news, including significant changes, regulatory updates, and guidance.
Council on Governmental Relations (COGR) COGR is tracking federal agency guidance to the COVID-19 health emergency and posting links as they come available.
OMB Memorandum

associated NSF Implementation Video for OMB Memo 
Administrative relief for recipients and applicants of federal financial assistance directly impacted by COVID-19 due to loss of operations 
CDC Interim Guidance for IHE Administrators    This interim guidance from the U.S. Centers for Disease Control and Prevention, intended for institutions of higher education, is based on what is currently known about the transmission and severity of coronavirus disease 2019 (COVID-19).
Institutional and Agency Responses to COVID-19 A collection of resources from various institutions of higher education compiled by the Council On Governmental Relations.
US FDA  Coronavirus (COVID-19) Update: FDA Issues Guidance for Conducting Clinical Trials
NSF Statement on Coronavirus (COVID-19) NSF actions in response to COVID-19. (Issued March 9)
Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients of NIH Funding The NIH is deeply concerned for the health and safety of people involved in NIH research, and about the effects on the biomedical enterprise in the areas affected by the HHS declared public health emergency for COVID-19. Due to the potential exceptional impact, we want to assure our recipient community that NIH will be doing our part to help you continue your research.

This is a rapidly evolving situation and we will provide updated guidance and information as it becomes available.
NIH COVID-19 FAQs NIH FAQs on Proposal Submission and Award Management Related to COVID-19 (Issued March 10)
NIH LATE APPLICATION POLICY Due to Public Health Emergency for United States for 2019 Novel Coronavirus (COVID-19) NIH special provisions implemented in response to COVID-19. (Issued March 9)
NSF COVID-19 FAQs Frequently Asked Questions (FAQs) About the Coronavirus Disease 2019 (COVID-19) for National Science Foundation (NSF) Proposers and Awardees.
PCORI Guidance Related to Impact of COVID-19 Description: PCORI recognizes that management of COVID-19 is a rapidly evolving and dynamic situation that may impact PCORI-funded awards. If you are encountering institutional or personal challenges or have other concerns related to your PCORI award, please reach out as soon as possible to your PCORI project team: Program Officer, Program Associate, and Contract Administrator. You may also reach us at fundedpfa@pcori.org.
OLAW Disaster Planning and Response Resources The Office of Laboratory Animal Welfare (OLAW) maintains a list of resources and has a list of FAQs, click on G9 to read about how to prepare for a pandemic.
Department of Defense  Frequently Asked Questions for DoD Research Proposers and Awardees Impacted by the Novel Coronavirus (COVID-19)
United States Army Medical Research Acquisition Activity (USAMRAA)   

The United States Army Medical Research Acquisition Activity (USAMRAA) is providing this information as a service to our applicant and recipient communities to address immediate, high-level questions that have been posed to federal research assistance agencies. Please note that given the fact that COVID-19 and associated impacts continue to evolve, applicants and recipients are strongly encouraged to monitor the resources noted below for updates. USAMRAA is publishing information on flexibilities for organizations funded by USAMRAA to conduct research on COVID-19 along with Frequently Asked Questions (FAQs) on other administrative flexibilities whose operations have been adversely impacted in the emergency response related to COVID-19.  These FAQs will be updated as more information becomes available.